Lastest from Businesswire

HONOLULU--(BUSINESS WIRE)--Central Pacific Financial Corp. (NYSE: CPF) (the "Company"), parent company of Central Pacific Bank (the "Bank" or "CPB"), today reported net income of $18.3 million, or fully diluted earnings per share ("EPS") of $0.67 for the second quarter of 2025, compared to net income of $17.8 million, or EPS of $0.65 in the previous quarter and net income of $15.8 million, or EPS of $0.58 in the year-ago quarter. "Our second quarter financial results demonstrate the continued s

SAN DIEGO--(BUSINESS WIRE)--The suit alleges defendants issued false statements concerning Fiserv business and prospects, resulting in its stock trading at inflated prices.

NEW YORK--(BUSINESS WIRE)--American Strategic Investment Co. (NYSE: NYC) (“ASIC” or the “Company”) announced today it will release its financial results as of, and for the second quarter ended June 30, 2025, on Friday, August 8, 2025, before the New York Stock Exchange open. The Company will also host a webcast and conference call the same day at 11:00 a.m. ET to review results and provide commentary on business performance. Dial-in instructions for the conference call and the replay are outlin

MUMBAI, India--(BUSINESS WIRE)-- #IT--Industry-focused specialist IT/ITES firm eClerx delivers strong Q1 FY26 performance

GRAND-LANCY, Switzerland--(BUSINESS WIRE)--Temenos (SIX: TEMN), a global leader in banking technology, announced it has been named in CNBC’s list of the World’s Top Fintech Companies for 2025 in the Enterprise Fintech category. The prestigious annual ranking, developed in partnership with market research firm Statista, recognizes the most impactful fintech companies driving transformation across financial services. Temenos was selected following a comprehensive evaluation of more than 2,000 glo

BARCELONA, Spain--(BUSINESS WIRE)--Almirall, S.A. (ALM) a global biopharmaceutical company based in Barcelona, today announced its financial results for the first half of 2025. The company continued to deliver strong sales growth in H1 2025, primarily driven by its dermatology business in Europe. Total Net Sales increased by 12.7% to €560.5 million, while EBITDA increased by 16.6% year-on-year to €121.8 million driven by higher sales growth and a gross profit of 65.5%. The European dermatology